In the news: 'Tempe company paves the way in nuclear medicine'
As a proud Tempe-based startup, we were thrilled to see this write-up in The Tempe Independent by news editor Lindsay Walker about our burgeoning work in the field of nuclear medicine—a field that, in the last year, saw an investment of more than $85 million from the U.S. Department of Energy.
While Serva's roots remain firmly in the development of Smart Nuclear Materials, our ability to develop life-saving medical isotopes used to help diagnose and treat a variety of diseases, including cancer, won us a coveted spot in the prestigious Mayo Clinic and ASU MedTech Accelerator.
Our disruptive software technology was the subject of Ms. Walker's article, which includes quotes from Dr. Sarah Jones, Vice President of Serva Medical, who led Serva's participation in the MedTech Accelerator.
"What our software does, essentially, is we can put in any radioisotope and tell you what all the pathways are to develop that, which is something that normally would have taken months to years to research and explore and put together," said Dr. Jones.